Clinical Cardiology

View the latest content related to this topic

News

Cardiac Injury in COVID-19 Sharply Increases Risk of Death

Wuhan researchers have published details on 416 hospitalized patients, but treatment pathways remain unclear.

Caitlin E. Cox

March 26, 2020

Slides

See all

Response by David Taggart, MD, PhD to the EXCEL Statement

Presenter: David Taggart

December 19, 2019

Presentation

AHA 2019

Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides on Statin Therapy: The EVAPORATE Study

Presenter: Matthew Budoff

November 18, 2019

Presentation

TCT Abstracts Posters 2019

Balloon Pulmonary Angioplasty for Patients with Symptomatic Chronic Thromboembolic Disease without Pulmonary Hypertension

Presenter: Yoichiro Matsuoka

September 30, 2019

Presentation

TCT Abstracts Posters 2019

Post-Cardiac Arrest Syndrome pilot study (PCAS-study). Impact of mulitorgan failure on early prognosis after out-of-hospital cardiac arrest.

Presenter: Piotr Buszman

September 29, 2019

Presentation

TCT 2019

Development of the Swan-Ganz Catheter: A Tale of Serendipity, Ingenuity, and Chance

Presenter: James Forrester

September 29, 2019

News

See all

News

COVID-19 Drug Candidates May Raise Arrhythmia Risk

By Caitlin E. Cox

April 03, 2020

News

ACC 2020

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

By Todd Neale

April 02, 2020

News

ACC 2020

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

By Michael O'Riordan

April 02, 2020

Editors Corner

TCTMD’s Top 10 Most Popular Stories for March 2020

By Shelley Wood

April 01, 2020

News

ACC 2020

Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients

By L.A. McKeown

April 01, 2020

CRT 2020

February 22

February 25, 2020

CTO 2020

February 19

February 21, 2020

Videos on This Topic

See all

REGISTER for free or LOG IN to view this content

June 14, 2019

Advertisement

Clinical Cardiology

Cardiac Injury in COVID-19 Sharply Increases Risk of Death

Slides

Response by David Taggart, MD, PhD to the EXCEL Statement

Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides on Statin Therapy: The EVAPORATE Study

Balloon Pulmonary Angioplasty for Patients with Symptomatic Chronic Thromboembolic Disease without Pulmonary Hypertension

Post-Cardiac Arrest Syndrome pilot study (PCAS-study). Impact of mulitorgan failure on early prognosis after out-of-hospital cardiac arrest.

Development of the Swan-Ganz Catheter: A Tale of Serendipity, Ingenuity, and Chance

News

COVID-19 Drug Candidates May Raise Arrhythmia Risk

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

TCTMD’s Top 10 Most Popular Stories for March 2020

Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients

More on This Topic

Upcoming Conferences

TVT 2020

Conference Coverage

CRT 2020

CTO 2020

Videos on This Topic

REGISTER for free or LOG IN to view this content

Advertisement

Advertisement

Clinical Cardiology

Slides

News

More on This Topic

Upcoming Conferences

Conference Coverage

Videos on This Topic

REGISTER for free or LOG IN to view this content

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content